mRNA vaccines can enhance immunotherapy efficacy by activating the immune system, improving outcomes in hard-to-treat tumors. mRNA COVID-19 vaccines enhance immune responses, improving cancer ...
Researchers have discovered that targeting PD-L1 recycling in myeloid cells enhances T-cell activation and boosts the effects ...
Triple therapy approach that hits cancer from multiple angles at once could be a game-changer against breast cancers that no longer respond to hormone treatment.
A specific subtype of tumor-associated macrophage is more abundant in endocrine therapy-resistant tumors, and targeting these ...
News Medical on MSN
New combination treatment overcomes resistance in ER positive breast cancer
In preclinical studies, researchers at Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School ...
Pfizer Inc. ( PFE) Discusses Clinical Development Strategy for 4404 Bispecific Antibody in Oncology November 10, 2025 8:30 AM EST ...
Rahway: Merck, known as MSD outside of the United States and Canada, has announced that the European Commission (EC) has ...
Validated Assay Can Test for Interferon Activity in Pediatric Inflammatory Diseases Using Biomarkers
The assay is fast and simple and has already shown clinical utility, although its interpretation may be limited by reference ...
The firm’s share price has nearly tripled over the past year, driven by steady cash flow, global expansion, and a distinct strategy.
OncoHost, a global leader in precision oncology and proteomics-based biomarker development, today announced the presentation of two new research posters at the 2025 International Society for Liquid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback